European I.V. Presence Lures Cardinal To Acquire Alaris For $2 Bil.
This article was originally published in The Gray Sheet
Executive Summary
The 18% premium Cardinal Health will pay for Alaris Medical Systems reflects the growing market presence of the I.V. medication safety device manufacturer